CYTIVA BIOPROCESS R & D AB has a total of 60 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2001. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets chemical engineering, biotechnology and measurement are GE HEALTHCARE BIOPROCESS R&D AB, SELECTIDE CORP and MGP BIOTECHNOLOGIES LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 22 | |
#2 | EPO (European Patent Office) | 18 | |
#3 | United States | 11 | |
#4 | Japan | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | United Kingdom | 2 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Chemical engineering | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Macromolecular chemistry and polymers | |
#5 | Machines | |
#6 | Computer technology | |
#7 | Mechanical elements |
# | Technology | |
---|---|---|
#1 | Chemical or physical processes | |
#2 | Separation | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Polysaccharides | |
#7 | Macromolecular compounds compositions | |
#8 | Unspecified technologies | |
#9 | Pipes | |
#10 | Computational chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Maloisel Jean-Luc | 13 |
#2 | Bjorkman Tomas | 13 |
#3 | Ander Mats | 12 |
#4 | Rodrigo Gustav | 10 |
#5 | Johansson Bo-Lennart | 9 |
#6 | Palmgren Ronnie | 6 |
#7 | Gebauer Klaus | 5 |
#8 | Johansson Hans J | 5 |
#9 | Hall Martin | 4 |
#10 | Glad Gunnar | 4 |
Publication | Filing date | Title |
---|---|---|
GB202101114D0 | PROCESS FOR mRNA PURIFICATION | |
GB202018588D0 | Separation matrix | |
WO2020221781A1 | Method for separation of antibodies or antibody fragments being devoid of an fc region capable of binding to protein a | |
WO2020221762A1 | Method of manufacturing agar or agarose beads | |
US2019144496A1 | Mutated immunoglobulin-binding polypeptides | |
EP3455243A1 | Separation matrix | |
EP2576502A1 | Novel chelator and use thereof |